|
|
BC-1
|
|
|
E Cesarman |
|
Biosafety Level: |
2 [CELLS CONTAIN HERPESVIRUS ]
|
|
|
frozen
|
|
Medium & Serum:
|
See Propagation
|
|
|
suspension |
|
|
Homo sapiens (human)
|
|
|
lymphoblast
|
|
|
Disease: lymphoma Cell Type: B lymphocyte; |
|
|
In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
|
|
|
|
transfection host (Roche FuGENE® Transfection Reagents) |
|
|
CD30 +; CD45 +; EMA + (epithelial membrane antigen) |
|
|
Amelogenin: X,Y CSF1PO: 10,11 D13S317: 8 D16S539: 12,13 D5S818: 11,12 D7S820: 11 THO1: 9.3 TPOX: 8,9 vWA: 16,20 |
|
|
46 years |
|
|
male |
|
|
ATCC complete growth medium: RPMI 1640 medium, 80%; fetal bovine serum, 20%
|
|
|
Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 5 X 10 exp5 cells/ml and maintain between 5 X 10 exp5 and 2 X 10 exp6 cells/ml. |
|
|
Culture medium, 95%; DMSO, 5% |
|
|
48 to 72 hrs |
|
|
22572: Moore PS, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J. Virol. 70: 549-558, 1996. PubMed: 8523568 23358: Cesarman E, et al. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86: 2708-2714, 1995. PubMed: 7670109 23395: Chadburn A, et al. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 72: 3078-3090, 1993. PubMed: 8221575 23493: Cesarman E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas. N. Engl. J. Med. 332: 1186-1191, 1995. PubMed: 7700311 |
|
|